Company Overview of Ritter Pharmaceuticals, Inc.
Ritter Pharmaceuticals, Inc., a biological therapeutics company, engages in the discovery, development, and commercialization of therapeutic treatments for gastrointestinal diseases and conditions. The company focuses on gastrointestinal physiology, metabolism, and gut adaptation associated with gastrointestinal diseases, including lactose intolerance, irritable bowel syndrome, crohn's disease, and ulcerative colitis. It develops RP-G28 for the treatment of lactose intolerance. The company was founded in 2004 and is based in Los Angeles, California.
1880 Century Park East
Los Angeles, CA 90067
Founded in 2004
Key Executives for Ritter Pharmaceuticals, Inc.
Ritter Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Sandoz Inc.||United States|
|MyoKardia, Inc.||United States|
|Asana BioSciences, LLC||United States|
|Ember Therapeutics, Inc.||United States|
|Tacere Therapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Chicago, IL | PwCPosted: Jul 18
- Philadelphia, PA | Healthcare ScoutsPosted: Jul 08
- Rockville, MD | Randstad EngineeringPosted: Jul 02
- Raleigh, NC | Arl BiopharmaPosted: Jul 12
Sponsored Financial Commentaries
To contact Ritter Pharmaceuticals, Inc., please visit www.ritterpharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.